이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Health Catalyst 과거 수익 실적
과거 기준 확인 0/6
Health Catalyst은 연평균 13.3%의 비율로 수입이 증가해 온 반면, Healthcare Services 산업은 연평균 8.3%의 비율로 수입이 증가했습니다. 매출은 연평균 16.6%의 비율로 증가했습니다.
주요 정보
13.3%
수익 성장률
68.6%
EPS 성장률
Healthcare Services 산업 성장 | 1.7% |
매출 성장률 | 16.6% |
자기자본 수익률 | -29.5% |
순이익 | -35.6% |
최근 수익 업데이트 | 31 Mar 2024 |
최근 과거 실적 업데이트
Recent updates
Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07Health Catalyst Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $70.63M beats by $0.75M
Aug 04Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jul 26수익 및 비용 분석
수익 및 비용 분석
Health Catalyst 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 |
---|